wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38424397-3E6CFAA5-C4D0-4AF5-8EA6-0F9D5552E09B
Q38424397-3E6CFAA5-C4D0-4AF5-8EA6-0F9D5552E09B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38424397-3E6CFAA5-C4D0-4AF5-8EA6-0F9D5552E09B
Therapies for triple negative breast cancer.
P2860
Q38424397-3E6CFAA5-C4D0-4AF5-8EA6-0F9D5552E09B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38424397-3E6CFAA5-C4D0-4AF5-8EA6-0F9D5552E09B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2af7fce0a9fb9ccdc34dce22e1fdc37230b76f4a
P2860
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†.